Figure:
Figure:. A) Relationship between the plasma trough concentration of nilotinib at 3 months and the major molecular response (MMR; ≤0.1% IS) by 12 months. . / B) Receiver-operating characteristic (ROC) curve of the plasma trough levels of nilotinib and their potential for discriminating an MMR. The area under the curve is 0.87 ± 0.07.

A) Relationship between the plasma trough concentration of nilotinib at 3 months and the major molecular response (MMR; ≤0.1% IS) by 12 months.

B) Receiver-operating characteristic (ROC) curve of the plasma trough levels of nilotinib and their potential for discriminating an MMR. The area under the curve is 0.87 ± 0.07.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal